Assessment of aortic stiffness by transthoracic echocardiographic in young COVID-19 patients

Basit Öğe Kaydı
dc.authorscopusid56527343200
dc.authorscopusid57660497200
dc.authorscopusid57658610400
dc.authorscopusid49762887000
dc.authorscopusid8708323200
dc.contributor.authorMansiroglu, Asli Kurtar
dc.contributor.authorDisikirik, Tuba
dc.contributor.authorSeymen, Hande
dc.contributor.authorCosgun, Mehmet
dc.contributor.authorSincer, Isa
dc.date.accessioned2024-09-25T19:45:06Z
dc.date.available2024-09-25T19:45:06Z
dc.date.issued2022
dc.departmentAbant İzzet Baysal Üniversitesien_US
dc.description.abstractBackground: Deteriorated aortic elasticity is part of the atherosclerotic process. Inflammation is an underlying factor in both COVID-19 and atherosclerosis. Aims and Objectives: Using aortic elastic properties, we aimed to assess the subclinical indicators of susceptibility to inflammatory atherosclerosis in patients with COVID-19. Materials and Methods: Out of 194 participants included in this study, 100 were diagnosed with COVID-19 in the last 6 months (60 women and 40 men with a mean age of 34.13 ± 6.45 years) and 94 were healthy controls (55 women and 39 men with a mean age of 30.39 ± 7.21 years). We analyzed transthoracic echocardiographic and aortic stiffness parameters in all participants. Results: Values of systolic blood pressure (110 [85-140] vs. 110 [80-140], P = 0.037) and pulse pressure (PP) (37 [25-55] vs. 40 [25-55], P < 0.01) were significantly different between the groups. As for laboratory parameters, levels of glucose (97.89 ± 20.23 vs. 92.00 ± 9.95, P = 0.003) and creatinine (0.80 ± 0.13 vs. 0.75 ± 0.09, P = 0.003) were significantly higher in the COVID-19 group. Echocardiographic parameters showed that both groups differed significantly in diastolic aortic diameter (2.42 ± 0.28 vs. 2.31 ± 0.35, P = 0.017), aortic strain (9.66 [1.20-31.82] vs. 12.82 [2.41-40.11], P = 0.025), aortic distensibility (0.502 [0.049-2.545] vs. 0.780 [0.120-2.674], P < 0.01), and aortic stiffness (16.67 [4.19-139.43] vs. 11.71 [3.43-65.21], P = 0.006). Conclusion: Measurement of aortic stiffness is a simple, practical yet inexpensive method in COVID-19 patients, and therefore, may be used as an early marker for COVID-19-induced subclinical atherosclerosis. © 2022 Wolters Kluwer Medknow Publications. All rights reserved.en_US
dc.identifier.doi10.4103/jcecho.jcecho_65_21
dc.identifier.endpage28en_US
dc.identifier.issn2211-4122
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-85129284641en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage23en_US
dc.identifier.urihttps://doi.org/10.4103/jcecho.jcecho_65_21
dc.identifier.urihttps://hdl.handle.net/20.500.12491/12855
dc.identifier.volume32en_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherWolters Kluwer Medknow Publicationsen_US
dc.relation.ispartofJournal of Cardiovascular Echographyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmzYK_20240925en_US
dc.subjectAortic distensibilityen_US
dc.subjectaortic stiffnessen_US
dc.subjectaortic strainen_US
dc.subjectCOVID-19en_US
dc.subjecttransthoracic echocardiographyen_US
dc.titleAssessment of aortic stiffness by transthoracic echocardiographic in young COVID-19 patientsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu